Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers 
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote 
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand 
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 
Tesla Launches New Model Y Variant in the US Starting at $41,990 
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War 
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says 
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins 
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate 
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 
EDEN PRAIRIE, Minn., Aug. 16, 2017 -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that John Erb, CEO, will be a featured presenter at the 6th Annual Intellisight Conference on Tuesday, August 22, 2017 from 3:35pm – 4:10pm central time in Minneapolis. Interested parties can view the Company’s live presentation via the website http://wsw.com/webcast/intel17/chfs and the webcast replay will remain accessible via the conference event page at: www.gointellisight.org.
The two-day Intellisight investor conference, hosted by the CFA Society of Minnesota, will take place this year on Tuesday and Wednesday, August 22 and 23, 2017 at University of St. Thomas’ Minneapolis Campus in the Schulze School of Entrepreneurship located in downtown Minneapolis. For further details, including registration information, please visit www.gointellisight.org or call the CFA Society at 612-317-2889.
About CHF Solutions
CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system, is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's objective is to improve the quality of life for patients with heart failure and related conditions. CHF Solutions is a Delaware corporation headquartered in Minneapolis with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.
For further information, please contact: Claudia Napal Drayton Chief Financial Officer CHF Solutions Inc. T: +1-952-345-4205 Investor Relations: CHF Solutions, Inc. [email protected] -or- Bret Shapiro Managing Partner CORE IR 516 222 2560 [email protected] www.coreir.com
